RNA interference inhibits replication of tick-borne encephalitis virus in vitro

Antiviral Research

Volumn 93, Issue 1, 2012, Pages 94-100

  Achazi, Katharina ^a   Patel, Pranav ^a   Paliwal, Ravish ^a   Radonić, Aleksandar ^a   Niedrig, Matthias ^a   Donoso Mantke, Oliver ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Antiviral drug; Flavivirus; RNA interference; Small interfering RNA; Tick borne encephalitis; Tick borne encephalitis virus

Indexed keywords

ANTIVIRUS AGENT; SMALL INTERFERING RNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SEQUENCE; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS GENOME; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; ENCEPHALITIS VIRUSES, TICK-BORNE; HEK293 CELLS; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

FLAVIVIRUS; IXODIDA; TICK-BORNE ENCEPHALITIS VIRUS;

EID: 84355161479     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.10.023     Document Type: Article

References (57)

1. Achazi K., Nitsche A., Patel P., Radonic A., Donoso Mantke O., Niedrig M. Detection and differentiation of tick-borne encephalitis virus subtypes by a reverse transcription quantitative real-time PCR and pyrosequencing. J. Virol. Methods 2011, 171:34-39.
2. Aebi C., Schaad U.B. TBE-immunoglobulins - A critical assessment of efficacy. Schweiz. Med. Wochenschr. 1994, 124:1837-1840.
3. Amarzguioui M., Prydz H. An algorithm for selection of functional siRNA sequences. Biochem. Biophys. Res. Commun. 2004, 316:1050-1058.
4. Bae H.G., Nitsche A., Teichmann A., Biel S.S., Niedrig M. Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J. Virol. Methods 2003, 110:185-191.
5. Bai F., Wang T., Pal U., Bao F., Gould L.H., Fikrig E. Use of RNA interference to prevent lethal murine West Nile virus infection. J. Infect. Dis. 2005, 191:1148-1154.
6. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001, 409:363-366.
7. Chu T.C., Twu K.Y., Ellington A.D., Levy M. Aptamer mediated siRNA delivery. Nucleic Acids Res. 2006, 34:e73.
8. Coburn G.A., Cullen B.R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 2002, 76:9225-9231.
9. Eekels J.J., Geerts D., Jeeninga R.E., Berkhout B. Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors. Antiviral Res. 2011, 89:43-53.
10. Federici T., Liu J.K., Teng Q., Yang J., Boulis N.M. A means for targeting therapeutics to peripheral nervous system neurons with axonal damage. Neurosurgery 2007, 60:911-918.
11. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
12. Grard G., Moureau G., Charrel R.N., Lemasson J.J., Gonzalez J.P., Gallian P., Gritsun T.S., Holmes E.C., Gould E.A., de Lamballerie X. Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy. Virology 2007, 361:80-92.
13. Gritsun T.S., Frolova T.V., Zhankov A.I., Armesto M., Turner S.L., Frolova M.P., Pogodina V.V., Lashkevich V.A., Gould E.A. Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J. Virol. 2003, 77:25-36.
14. Guil S., Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol. 2009, 41:87-95.
15. Haasnoot J., Berkhout B. RNA interference. its use as antiviral therapy. Handb. Exp. Pharmacol. 2006, 117-150.
16. Haasnoot J., Westerhout E.M., Berkhout B. RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 2007, 25:1435-1443.
17. Haasnoot P.C., Cupac D., Berkhout B. Inhibition of virus replication by RNA interference. J. Biomed. Sci. 2003, 10:607-616.
18. Hajeri P.B., Singh S.K. SiRNAs: their potential as therapeutic agents - Part I. Designing of siRNAs. Drug Discov. Today 2009, 14:851-858.
19. Hammond S.M., Boettcher S., Caudy A.A., Kobayashi R., Hannon G.J. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001, 293:1146-1150.
20. Hannon G.J., Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 2004, 431:371-378.
21. Harper S.Q., Staber P.D., He X., Eliason S.L., Martins I.H., Mao Q., Yang L., Kotin R.M., Paulson H.L., Davidson B.L. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 2005, 102:5820-5825.
22. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., Noronha A., Manoharan M., Akira S., de Fougerolles A., Endres S., Hartmann G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005, 11:263-270.
23. Huang F., Zhou J., Yang Z., Cui L., Zhang W., Yuan C., Yang S., Zhu J., Hua X. RNA interference inhibits hepatitis E virus mRNA accumulation and protein synthesis in vitro. Vet. Microbiol. 2010, 142:261-267.
24. Jacque J.M., Triques K., Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418:435-438.
25. Katiyar-Agarwal S., Morgan R., Dahlbeck D., Borsani O., Villegas A., Zhu J.K., Staskawicz B.J., Jin H. A pathogen-inducible endogenous siRNA in plant immunity. Proc. Natl. Acad. Sci. USA 2006, 103:18002-18007.
26. Kim D.H., Rossi J.J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 2007, 8:173-184.
27. Kumar P., Lee S.K., Shankar P., Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med. 2006, 3:e96.
28. Kumar P., Wu H., McBride J.L., Jung K.E., Kim M.H., Davidson B.L., Lee S.K., Shankar P., Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448:39-43.
29. Lin D., Li L., Dick D., Shope R.E., Feldmann H., Barrett A.D., Holbrook M.R. Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus. Virology 2003, 313:81-90.
30. Lindquist L., Vapalahti O. Tick-borne encephalitis. Lancet 2008, 371:1861-1871.
31. Manfredsson F.P., Mandel R.J. The development of flexible lentiviral vectors for gene transfer in the CNS. Exp. Neurol. 2011, 229:201-206.
32. Mansfield K.L., Johnson N., Phipps L.P., Stephenson J.R., Fooks A.R., Solomon T. Tick-borne encephalitis virus - A review of an emerging zoonosis. J. Gen. Virol. 2009, 90:1781-1794.
33. Mathonnet G., Fabian M.R., Svitkin Y.V., Parsyan A., Huck L., Murata T., Biffo S., Merrick W.C., Darzynkiewicz E., Pillai R.S., Filipowicz W., Duchaine T.F., Sonenberg N. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 2007, 317:1764-1767.
34. McNamara J.O., Andrechek E.R., Wang Y., Viles K.D., Rempel R.E., Gilboa E., Sullenger B.A., Giangrande P.H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 2006, 24:1005-1015.
35. Muller M.A., Paweska J.T., Leman P.A., Drosten C., Grywna K., Kemp A., Braack L., Sonnenberg K., Niedrig M., Swanepoel R. Coronavirus antibodies in African bat species. Emerg. Infect. Dis. 2007, 13:1367-1370.
36. Murakami M., Ota T., Nukuzuma S., Takegami T. Inhibitory effect of RNAi on Japanese encephalitis virus replication in vitro and in vivo. Microbiol. Immunol. 2005, 49:1047-1056.
37. Navarro L., Dunoyer P., Jay F., Arnold B., Dharmasiri N., Estelle M., Voinnet O., Jones J.D. A plant miRNA contributes to antibacterial resistance by repressing auxin signaling. Science 2006, 312:436-439.
38. Niedrig M., Klockmann U., Lang W., Roeder J., Burk S., Modrow S., Pauli G. Monoclonal antibodies directed against tick-borne encephalitis virus with neutralizing activity in vivo. Acta Virol. 1994, 38:141-149.
39. Niedrig M., Lademann M., Emmerich P., Lafrenz M. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Tropical Med. Int. Health 1999, 4:867-871.
40. Noack R. Postexpositionelle FSME-Immunglobulingabe im Kindesalter nicht. Mehr zu empfehlen. Monatsschr. Kinderheilkd. 1997, 145:416-417.
41. Pacca C.C., Severino A.A., Mondini A., Rahal P., D'Avila S.G., Cordeiro J.A., Nogueira M.C., Bronzoni R.V., Nogueira M.L. RNA interference inhibits yellow fever virus replication in vitro and in vivo. Virus Genes 2009, 38:224-231.
42. Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 2004, 313:856-862.
43. Ray D., Shi P.Y. Recent advances in flavivirus antiviral drug discovery and vaccine development. Recent Pat. Antiinfect. Drug Discov. 2006, 1:45-55.
44. Singh S.K., Hajeri P.B. SiRNAs: their potential as therapeutic agents - Part II. Methods of delivery. Drug Discov. Today 2009, 14:859-865.
45. Sioud M. Ribozyme- and siRNA-mediated mRNA degradation: a general introduction. Methods Mol. Biol. 2004, 252:1-8.
46. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 2003, 9:347-351.
47. Stein D.A., Shi P.Y. Nucleic acid-based inhibition of flavivirus infections. Front. Biosci. 2008, 13:1385-1395.
48. Stevenson M. Therapeutic potential of RNA interference. N. Engl. J. Med. 2004, 351:1772-1777.
49. Süss J. Tick-borne encephalitis in Europe and beyond-the epidemiological situation as of 2007. Euro Surveill. 2008, 13:pii: 18916.
50. Valdueza J.M., Weber J.R., Harms L., Bock A. Severe tick borne encephalomyelitis after tick bite and passive immunisation. J. Neurol. Neurosurg. Psychiatry 1996, 60:593-594.
51. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20:515-524.
52. Van den Haute C., Eggermont K., Nuttin B., Debyser Z., Baekelandt V. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene Ther. 2003, 14:1799-1807.
53. Waldvogel K., Bossart W., Huisman T., Boltshauser E., Nadal D. Severe tick-borne encephalitis following passive immunization. Eur. J. Pediatr. 1996, 155:775-779.
54. Weinberg M.S., Arbuthnot P. Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection. Genome Med. 2010, 2:28.
55. Westerhout E.M., Berkhout B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res. 2007, 35:4322-4330.
56. Wu X., Hong H., Yue J., Wu Y., Li X., Jiang L., Li L., Li Q., Gao G., Yang X. Inhibitory effect of small interfering RNA on dengue virus replication in mosquito cells. Virol. J. 2010, 7:270.
57. Zhang Y.L., Cheng T., Cai Y.J., Yuan Q., Liu C., Zhang T., Xia D.Z., Li R.Y., Yang L.W., Wang Y.B., Yeo A.E., Shih J.W., Zhang J., Xia N.S. RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. BMC Microbiol. 2010, 10:214.